Monday, April 17, 2017

Latest Blood Pressure Monitor


Omron Squeezed an Inflatable Blood Pressure Monitor Into a Watch




Almost every wrist-worn fitness tracker now includes a sensor that can track the wearer’s heart rate as another useful fitness metric. But Omron is the first company with a wearable device that can also monitor blood pressure which provides more useful insights into the wearer’s health.
That’s not to imply that you shouldn’t seek medical attention when your heart rate soars after simply struggling to open a fridge door, but there’s a good reason why hospitals strap the inflatable cuff of a sphygmomanometer to your arm as soon as you’ve been admitted.
Measuring your blood pressure can reveal serious conditions like hypertension or hypotension, but until now the most accurate way to get a reading was using a large inflatable cuff wrapped around a patient’s upper arm. Measuring blood pressure at the wrist is an option, but the Omron Project Zero Wrist Blood Pressure Monitor is the first watch-sized sphygmomanometer that promises readings as accurate as what you’d get from upper arm models.
Pricing and availability for the Project Zero is still undetermined as Omron works to complete certification and FDA-testing on the device, but the company claims it will be accurate enough to be certified for use in hospitals and medical facilities.
Because Omron uses a miniaturized version of the inflatable cuff found on larger blood pressure monitors, the Project Zero isn’t quite as svelte as a wearable like the Apple Watch, but it can still be worn day and night as a fitness tracker if you don’t mind a little extra bulk on your wrist.


In addition to measuring blood pressure, Omron’s over-sized wearable also tracks other fitness metrics like physical activity, or even the quality of your sleep over night. And all of that information can be wirelessly synced with the Omron Connect app, available for iOS or Android devices, allowing users to keep tabs on their health progress over time, or to send health reports to a physician for remote monitoring of a condition.
Most fitness enthusiasts probably don’t need to keep tabs on their blood pressure on a minute-by-minute basis, and there’s little doubt the Project Zero Wrist Blood Pressure Monitor will eventually hit the market at a price point higher than most fitness trackers. But compared to the blood pressure monitors that hospitals have to wheel from room to room and patient to patient, the Project Zero will also certainly be a cheaper and more convenient solution for keeping tabs on a patient’s blood pressure. In other words, there will be no shortage of interested buyers for this one.

Tuesday, February 23, 2016

Noninvasive monitoring of blood pressure using optical Ballistocardiography and Photoplethysmograph approaches.


Abstract

A new all optical method for long term and continuous blood pressure measurement and monitoring without using cuffs is proposed by using Ballistocardiography (BCG) and Photoplethysmograph (PPG). Based on BCG signal and PPG signal, a time delay between these two signals is obtained to calculate both systolic blood pressure and diastolic blood pressure via linear regression analysis. The fabricated noninvasive blood pressure monitoring device consists of a fiber sensor mat to measure BCG signal and a SpO2 sensor to measure PPG signal. A commercial digital oscillometric blood pressure meter is used to obtain reference values and for calibration. It has been found that by comparing with the reference device, our prototype has typical means and standard deviations of 9+/-5.6 mmHg for systolic blood pressure, 1.8+/-1.3 mmHg for diastolic blood pressure and 0.6+/-0.9 bpm for pulse rate, respectively. If the fiber optic SpO2 probe is used, this new all fiber cuffless noninvasive blood pressure monitoring device will truly be a MRI safe blood pressure measurement and monitoring device.
PMID:
 
24110216
 
[PubMed - indexed for MEDLINE]

New Startup Develops Continuous Blood Pressure Measurement Without a Counter-Pressure Cuff



Sense A/S out of Taastrup, Denmark is developing a continuous blood pressure monitor that doesn’t rely on a typical pressure cuff, but rather on a patch that has electrodes that sense the changing impedance of tissue around a vessel and convert it into a BP reading. Measuring other characteristics in electrical signal can also identify vascular stiffness and pulse velocity.
The company just raised € 4.5 million in a third investment round and believes that a 510(k) approval from the FDA is likely sufficient to get the device to market.
The Danish company Sense A/S develops ContiPress™, which continuously measures the patient’s blood pressure 24 hours a day, down to every 10 second day and night, without the user noticing. ContiPress™ consists of an intelligent patch, which the doctor or nurse places on the patient’s upper arm. From there, the unit monitors the patient’s blood pressure over 24 hours and stores the data for subsequent analysis via an enclosed piece of software. The result is comprehensive data about the patient’s blood pressure over 24 hours and thus an optimal basis for making the correct diagnosis.
Sense has raised € 4.5 million in an investment round with venture fund SEED Capital and Vækstfonden. It is the company third round, since it was founded in 2006 in connection with an investment from SEED Capital. Second round of investment came from SEED Capital and Vækstfonden in 2010. ContiPress™ is currently a prototype that has been clinically tested on people with very large differences in both blood pressure, BMI (body mass index) and age with promising results that verify the measurement principle. The investment round will be used to refine the device and try ContiPress™ in a more extensive clinical testing within the expected commercial launch.

Sunday, February 22, 2015

Dispute between Nordic Partnership and Ms Nita Sah and Mr Sandeep Sha Tarillian

Nordic Partnership was given an exclusive mandate by Tarillian to raise funds based on representations made by the directors who were advised by their lawyers that they would need to provide directors guarantees in respect to all representations made  to date, and Tarillian just at the closing stages of the mandate  have now  terminated this mandate  and disputed that any exclusive mandate was ever given to Nordic to raise any funds.

Nordic Partnership was in the final stages of closing the funding and apologises to all investors who have spent time and money undertaking due diligence based on representations made by Tarillian and or its directors.

Nordic Partnership have ask Tarillian for full disclosure in respect to the companies financial state of health and any other loans the company may have that were not disclosed to Nordic Partnership.


Until this dispute is resolved no further fund raising will  be undertaken. 

If you have any further questions please do not hesitate to contact us on + 44 0207 193 3604 

Wednesday, November 19, 2014

Nordic Partnership - Presentation for project blood for HIgh Net Worth Investors

Nordic Partnership has been given an exclusive mandate to raise funds in order that a UK company can  manufacture a new blood test monitor that  is accurate and simple to use.

Data Room will be open to qualified investors who have signed  the NDA from Thursday 27th November 2014. 


To access data room you need to sign this NDA agreement click here


The current fund raising is due to close shortly when the minimum fund raise of  $2.3m is reached.

If you have any questions please call +44 0207 193 3604







High blood pressure 'costs £2bn'

High blood pressure is costing the NHS billions of pounds every year, a study saysIn the first calculation of its kind, PHE said the annual cost to the NHS in England from diseases caused by high blood pressure is an estimated £2.1 billion.
High blood pressure is costing the NHS billions of pounds every year, a study says

Diseases caused by high blood pressure cost the NHS more than £2 billion every year, new figures have revealed.© by 
Public Health England (PHE) is today launching an unprecedented programme to tackle the condition, which can lead to heart attacks, strokes and chronic kidney disease.
The figures also show that reducing the blood pressure of the country as a whole could save £850 million in spending on health and social care over 10 years.
More than five million people are unaware that they have high blood pressure even though it affects more than one in four adults and accounts for 12% of all visits to GPs in England.
PHE said that if 15% more people who are unaware they have the condition are diagnosed, £120 million could be saved over a decade.
And if another 15% of those currently being treated for high blood pressure controlled it better, a further £120 million could be spared.  
PHE has established the Blood Pressure System Leadership Board, a collection of public bodies, charities and experts.
The group today publishes an action plan setting out steps to improve the prevention, early detection and management of high blood pressure in England in a bid to replicate successes in the area seen in the US and Canada.
Professor Kevin Fenton, national director of health and well-being at Public Health England, said: "Too many people are dying prematurely from preventable conditions and high blood pressure plays a big part in this.
"It is vital for partners to come together to tackle this - from local government, to the health service and charities, we all have a role to play.
Professor Graham MacGregor, chairman of Blood Pressure UK said; "There are over five million people walking around like a ticking time bomb, unaware that they are at risk of having a stroke or a heart attack due to their blood pressure."
Groups across society are being encouraged to take steps to reduce the prevalence of high blood pressure.
Measures set out in the action plan include encouraging families to make changes to their diet and their salt intake in particular, as well as urging those at risk to monitor blood pressure levels regularly and raise any changes with their doctor.
Companies are also being urged to " offer high-quality workplace blood pressure testing to staff".
People from the most deprived areas are 30% more likely to have high blood pressure and the initiative also aims to focus on this group to encourage healthy diets and regular testing.
Professor Huon Gray, national clinical director for Heart Disease for NHS England, said: "Over half of all strokes and many heart attacks could be prevented by ensuring people take steps to get their blood pressure into the normal range, but, unfortunately, high blood pressure often goes unrecognised.
"It's essential that everyone has their blood pressure checked regularly and by taking simple steps like cutting some salt from the diet, or taking more exercise, high blood pressure can be reduced. Left untreated, high blood pressure can lead to disability, or even death."
Public Health Minister Jane Ellison said: "Any new initiative which will improve people's health and well-being as well as saving the NHS money is to be applauded.
"Our goal is to prevent people from developing high blood pressure in the first place - by helping people to eat better, lose weight, exercise more and reduce stress."
Dr Janet Atherton, president of the Association of Directors of Public Health, said: "Population prevention measures - such as reducing salt in the diet and tackling obesogenic environments - alongside better early detection and treatment, will mean that rapid improvements in the public's health can be achieved, together with significant savings to a hard-pressed health and social care system."
PHE has also launched a new blood pressure quiz allowing people to test their knowledge of the issue.